摘要
Hepatocellular carcinoma(HCC)is the most frequent primary liver cancer,and surgical resection offers an opportunity for cure in patients fortunate enough to have tumors amenable to resection.Unfortunately,recurrence rates are as high as 70%five years after resection,and recurrent disease proves to be a major obstacle to improving prognosis.Many adjuvant treatments have been utilized after resection in hopes of improving survival and have failed.This review outlines previous adjuvant strategies for patients with resected HCC and discusses potential steps forward to finding a successful adjuvant therapy.
